Evidence map›Paper›PMID 39968416›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2025

MONet: cancer driver gene identification algorithm based on integrated analysis of multi-omics data and network models.

Yingzan Ren, Tiantian Zhang, Jian Liu, Fubin Ma, Jiaxin Chen, Ponian Li, Guodong Xiao, Chuanqi Sun, Yusen Zhang

Abstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yingzan Ren *School of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Tiantian Zhang *School of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Jian LiuSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Fubin MaSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Jiaxin ChenSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Ponian LiSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Guodong XiaoSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Chuanqi SunSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.
Yusen ZhangSchool of Mathematics and Statistics, Shandong University, Weihai, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer progression is orchestrated by the accrual of mutations in driver genes, which endow malignant cells with a selective proliferative advantage. Identifying cancer driver genes is crucial for elucidating the molecular mechanisms of cancer, advancing targeted therapies, and uncovering novel biomarkers. Based on integrated analysis of Multi-Omics data and Network models, we present MONet, a novel cancer driver gene identification algorithm. Our method utilizes two graph neural network algorithms on protein-protein interaction (PPI) networks to extract feature vector representations for each gene. These feature vectors are subsequently concatenated and fed into a multi-layer perceptron model (MLP) to perform semi-supervised identification of cancer driver genes. For each mutated gene, MONet assigns the probability of being potential driver, with genes identified in at least two PPI networks selected as candidate driver genes. When applied to pan-cancer datasets, MONet demonstrated robustness across various PPI networks, outperforming baseline models in terms of both the area under the receiver operating characteristic curve and the area under the precision-recall curve. Notably, MONet identified 37 novel driver genes that were missed by other methods, including 29 genes such as APOBEC2, GDNF, and PRELP, which are corroborated by existing literature, underscoring their critical roles in cancer development and progression. Through the MONet framework, we successfully identified known and novel candidate cancer driver genes, providing biologically meaningful insights into cancer mechanisms.

Indexed as

AlgorithmsComputational BiologyNeoplasmsGene Regulatory NetworksGenomicsHumansMultiomicsMutationNeural Networks, ComputerProtein Interaction Mapsdriver genesgraph attention networkgraph convolutional networkmulti-omics datapan-cancer

Identifiers

PMID39968416
PMCPMC11834253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.